Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Calcipotriol Cream/Ointment bulk supplier for pharma manufacturers

Calcipotriol Cream/Ointment 0.005%, Suppliers & Bulk Manufacturers

Available Forms: Cream, Ointment

Available Strengths: 0.005%,

Reference Brands: Daivobet, Calcipotriol(US)

Category: Derma Drugs

Calcipotriol cream and ointment are vitamin D analogs that regulate skin cell production and reduce inflammation. They effectively treat psoriasis by slowing abnormal skin growth, decreasing scaling and redness. Benefits include clearer skin, reduced itching, and improved skin health when used as prescribed.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Calcipotriol cream and ointment are approved in the EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP and IVDR standards. In the US, calcipotriol is not widely approved and is primarily used in compounded formulations under medical supervision. In the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations, with extensive validation, stability testing, and quality audits conducted. Proper documentation includes safety profiles, clinical data, and manufacturing details. For detailed licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective calcipotriol formulations for psoriasis treatment worldwide.

Calcipotriol Cream/Ointment — third party manufacturing & bulk supply

Calcipotriol Cream/Ointment 0.005%, is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Calcipotriol Cream/Ointment is supplied as Cream, Ointment — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Calcipotriol Cream/Ointment listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Calcipotriol Cream/Ointment →
Back to Listing

Frequently Asked Questions

Calcipotriol Cream/Ointment is listed as Cream, Ointment in 0.005%,. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Calcipotriol Cream/Ointment is referenced against Daivobet, Calcipotriol(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Glycopyrronium Tosylate

Strength:
2.4%

Form:

Reference Brands: Qbrexza (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.